Blog
Applying Precision Genomics in Biopharma Drug Development
BlogA recent collaboration between Onconova Therapeutics and Mission will utilize the Mission Bio TapestriⓇ Platform to conduct targeted single-cell DNA analysis for the study of Onconova's novel cancer therapy, Rigosertib. We spoke with Darrin Crisitello, CCO of Mission Bio, to learn more.
One-by-One and All-at-Once: The Future of Cellular Phenotypic Screening
BlogAs scientists, we’re often subjected to certain stereotypes. We’re assumed to be smart and nerdy; we work long hours, wear lab coats, and obsess over data. Some or all of these traits and behaviors may ring true at a population level, but for individual scientists they don’t always stack up. The same disconnect applies to cells. We assume that the average phenotype is representative of all of the members of a population, but too often it is not...
Read More
First-of-Its-Kind Lipidomics Excellence Award Acknowledges Forward-thinking in a Rapidly Growing Field
BlogTechnology Networks recently visited Dresden, Germany, for Lipotype's Lipid Excellence Award press talk, where we gained insights into the past, present and future of lipidomics research.
Read More
Measuring Millions of Protein–Protein Interactions Simultaneously
BlogWe recently had the pleasure of speaking with David Younger, PhD., Co-founder and CEO of A-Alpha Bio, to learn more about AlphaSeq – a platform designed to measure millions of protein–protein interactions simultaneously.
Read More
Cell Conversions Transformed From Black Box Guesswork to Systematic Discovery
BlogPredicting the reprogramming factors necessary to induce cell conversion has largely relied on trial and error, revealing the need for a more systematic approach. To learn about Mogrify's approach to achieving cell conversion through transdifferentiation, we interviewed Pierre-Louis Joffrin, Corporate Development Executive at Mogrify.
Read More
Empowering Cancer Patients After Diagnosis
BlogWe recently spoke with Jed Coleman, co-founder of Curve.life, an online service aiming to provide cancer patients with evidence-based information about how they can empower themselves after diagnosis.
Read More
Technology Networks Explores the CRISPR Revolution – Coming Soon
BlogThrough a series of exclusive interviews with world-renowned scientists and bioethicists, Technology Networks Explores the CRISPR Revolution will investigate the ground-breaking research taking place in the CRISPR space, CRISPR "controversies" and whether the CRISPR technology looks set to fulfil its promise of revolutionizing science.
Read More
Food Poisoning Bacteria’s Sugar Coating Could Be Its Undoing
BlogTo learn how Campylobacter hides from the body’s immune system, why some people are more susceptible than others, and the potential role that carbohydrate-based diagnostics could play in the fight against the bacterium, we spoke to Professor Rob Field, Co-founder of Iceni Diagnostics.
Read More
Exploring the Fourth Dimension of Proteome Analysis
BlogRecent developments in MS technology have enabled a fourth dimension of analysis: ion mobility separation. The term "4D proteomics" has been created to describe analysis that incorporates all four dimensions. We interviewed two researchers at the forefront of the proteomics field to learn more about how 4D proteomics approaches are enhancing their research.
Clinical Proteomics and Computational Biochemistry With Professor Jürgen Cox
BlogTechnology Networks recently spoke with Professor Jürgen Cox to learn more about the computational software tools his laboratory are developing, and how 4D proteomics workflows enhance research in clinical proteomics.
Read More
